Point-of-Care Testing and Creatinine Measurement

dc.contributor.authorShephard, M.
dc.date.issued2011
dc.description.abstractThis paper reviews the current status of point-of-care testing (PoCT) devices that are available for measuring whole blood or serum/plasma creatinine globally and within Australasia. Information on non-analytical specifications and analytical performance is provided using data sourced from recently published literature, external quality assurance programs and evaluative work by the author’s unit. The limitations of current devices are summarised.
dc.description.statementofresponsibilityMark D.S. Shephard
dc.description.urihttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC3100277/
dc.identifier.citationClinical Biochemist Reviews, 2011; 32(2):109-114
dc.identifier.issn0159-8090
dc.identifier.issn1838-0212
dc.identifier.urihttp://hdl.handle.net/2440/71635
dc.language.isoen
dc.publisherAssociated Business Publications Pty Ltd
dc.rightsCopyright status unknown
dc.titlePoint-of-Care Testing and Creatinine Measurement
dc.typeJournal article
pubs.publication-statusPublished

Files